Clinical Trial Update: Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients [NA]

View source ↗

Summary

A Columbia University-sponsored clinical trial evaluating Apricity CARE to improve immune checkpoint inhibitor outcomes in ethnically/racial minority patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Columbia University | Conditions: Non Small Cell Lung Cancer | NA | Status: COMPLETED